Maricel Apuli serves as Executive at BridgeBio Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Maricel Apuli has executed 5 insider transactions totaling $280.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 26, 2026 involved selling 2,000 shares valued at $132.0K.
Maricel Apuli currently holds 121,945 shares of BridgeBio Pharma, Inc. (BBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Maricel Apuli has been a net seller of BBIO stock. They have purchased $0 and sold $280.5K worth of shares.
Maricel Apuli's most recent insider trade was on Feb 26, 2026, when they sold 2,000 shares at $66.00 per share.
Get notified when new Form 4 filings are submitted
| $75.15 |
| Discretionary |
| Dec 8, 2025 | BBIO | $148.5K | Sale | 2,000 | $74.26 | Discretionary |
| Nov 16, 2025 | BBIO | $317.4K | Payment | 4,781 | $66.39 | Discretionary |
| Aug 16, 2025 | BBIO | $245.4K | Payment | 4,781 | $51.32 | Discretionary |